MYH10

Chr 17

myosin heavy chain 10

Also known as: NMMHC-IIB, NMMHCB

This gene encodes a member of the myosin superfamily. The protein represents a conventional non-muscle myosin; it should not be confused with the unconventional myosin-10 (MYO10). Myosins are actin-dependent motor proteins with diverse functions including regulation of cytokinesis, cell motility, and cell polarity. Mutations in this gene have been associated with May-Hegglin anomaly and developmental defects in brain and heart. Multiple transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Dec 2011]

OMIMResearchGenerating clinical summary…
DNmechanismLOEUF 0.17
Clinical SummaryMYH10
🧬
Gene-Disease Validity (ClinGen)
complex neurodevelopmental disorder with or without congenital anomalies · ADDefinitive

Definitive — sufficient evidence for diagnostic panels

Population Constraint (gnomAD)
Highly constrained gene — heterozygous loss-of-function variants are very rare in the population (pLI 1.00). One damaged copy is likely sufficient to cause disease.
📋
ClinVar Variants
15 unique Pathogenic / Likely Pathogenic· 278 VUS of 368 total submissions

Population Genetics & Constraint

gnomAD v4 — loss-of-function & missense intolerance

Dual constrained — LoF & missense intolerant
LoF Constraint?
0.17LOEUF
pLI 1.000
Z-score 8.96
OE 0.10 (0.070.17)
Highly constrained

Highly LoF-intolerant (top ~10% of genes)

Missense Constraint?
5.01Z-score
OE missense 0.58 (0.550.62)
671 obs / 1148.4 exp
Constrained

Extremely missense-constrained (top ~0.01%)

Observed / Expected Ratios?
LoF OE?0.10 (0.070.17)
00.351.4
Missense OE?0.58 (0.550.62)
00.61.4
Synonymous OE?0.93
01.21.6
LoF obs/exp: 12 / 116.2Missense obs/exp: 671 / 1148.4Syn Z: 1.19
Curated Mechanism (G2P)Gene2Phenotype (DDG2P) ↗
moderateMYH10-related multiple congenital anomaliesDNAD

This gene — mechanism propensity

DN
0.5967th %ile
GOF
0.4283th %ile
LOF
0.57top 25%

This gene has evidence for multiple mechanisms of pathogenicity (loss-of-function and dominant-negative). The Badonyi & Marsh model scores dominant-negative highest among its predictions, but genomic evidence (constraint, ClinVar variant spectrum, and literature) most strongly supports loss-of-function (haploinsufficiency). Different variants in this gene may act through different mechanisms — interpret in context of the specific variant.

LOF47% of P/LP variants are LoF · LOEUF 0.17
DN1 literature citation

Note: In-silico variant effect predictors (SIFT, PolyPhen, REVEL, CADD) may underestimate pathogenicity of missense variants in genes with GOF or DN mechanisms. Consider functional evidence and clinical context.

Literature Evidence

DNMYH10 variant overexpression produced a dominant-negative effect on ciliary length.1

Predictions from Badonyi M, Marsh JA. PLoS ONE. 2024;19(8):e0307312. Mechanism ranking also informed by gnomAD constraint, ClinVar, and ClinGen data.

References

  1. 1.PMID 35980381

ClinVar Variant Classifications

368 submitted variants in ClinVar

Classification Summary

Pathogenic6
Likely Pathogenic9
VUS278
Likely Benign26
Benign16
Conflicting1
6
Pathogenic
9
Likely Pathogenic
278
VUS
26
Likely Benign
16
Benign
1
Conflicting

Curated Variants Distribution

Classified variants from ClinVar · 5 ACMG categories

ClassificationLoFMissense + InframeNon-codingSynonymousTotal
Pathogenic
4
2
0
0
6
Likely Pathogenic
3
6
0
0
9
VUS
19
256
2
1
278
Likely Benign
0
5
8
13
26
Benign
0
3
5
8
16
Conflicting
1
Total262721522336

LoF = frameshift, stop gained/lost, canonical splice · Counts from ClinVar esearch · Updated hourly

View in ClinVar →

11 pathogenic / likely-pathogenic (of 16) ClinVar copy-number / structural variants overlap MYH10 — these span large chromosomal regions, not the gene specifically, and are excluded from the counts above. Explore in CNV tools →

Protein Context — Lollipop Plot

MYH10 · protein map & ClinVar variants

Showing all ClinVar variants across the protein. Search a specific variant to highlight its position.

Clinical Trials

Active and recruiting trials from ClinicalTrials.gov

No active trials found for this gene.

Search ClinicalTrials.gov →